Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burris

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Annales Chirurgiae Et Gynaecologiae|July 19, 2001
Blood substitutes in surgeryD Burris
Hospital Materiel Management Quarterly|October 8, 1980
Implementing a unit dose drug distribution systemL S Wrobel, D Burris
The New England Journal of Medicine|February 20, 2004
Images in clinical medicine. Ocular melanocytosisJames Chodosh, Russell D Burris
Molecular Pharmacology|November 1, 1992
Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamideK D Burris, E Sanders-Bush
Studies in Health Technology and Informatics|October 28, 1999
Telepresence surgery system enhances medical student surgery trainingC Kaufmann, P Rhee, D Burris
Journal of Biomolecular Screening|May 22, 2016
JBS Special Issue: Innovative Screening Methodologies to Identify New Compounds for the Treatment of Central Nervous System DisordersKevin D Burris, Steven I Dworetzky
Studies in Health Technology and Informatics|September 8, 2000
DTI autostereographic display: initial evaluationC Kaufmann, A Liu, D Burris
Molecular and Cellular Endocrinology|March 30, 2021
Steroidogenic cytochrome P450 17A1 structure and functionSarah D Burris-Hiday, Emily E Scott
The Journal of Biological Chemistry|July 30, 2023
Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domainSarah D Burris-Hiday, Emily E Scott
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1991
(+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonistK D Burris, M Breeding, E Sanders-Bush
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Annales Chirurgiae Et Gynaecologiae|July 19, 2001
Blood substitutes in surgeryD Burris
Hospital Materiel Management Quarterly|October 8, 1980
Implementing a unit dose drug distribution systemL S Wrobel, D Burris
The New England Journal of Medicine|February 20, 2004
Images in clinical medicine. Ocular melanocytosisJames Chodosh, Russell D Burris
Molecular Pharmacology|November 1, 1992
Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamideK D Burris, E Sanders-Bush
Studies in Health Technology and Informatics|October 28, 1999
Telepresence surgery system enhances medical student surgery trainingC Kaufmann, P Rhee, D Burris
Journal of Biomolecular Screening|May 22, 2016
JBS Special Issue: Innovative Screening Methodologies to Identify New Compounds for the Treatment of Central Nervous System DisordersKevin D Burris, Steven I Dworetzky
Studies in Health Technology and Informatics|September 8, 2000
DTI autostereographic display: initial evaluationC Kaufmann, A Liu, D Burris
Molecular and Cellular Endocrinology|March 30, 2021
Steroidogenic cytochrome P450 17A1 structure and functionSarah D Burris-Hiday, Emily E Scott
The Journal of Biological Chemistry|July 30, 2023
Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domainSarah D Burris-Hiday, Emily E Scott
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1991
(+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonistK D Burris, M Breeding, E Sanders-Bush
Pageof 8